Yahoo to Participate at the Citi Global Technology Conference

SUNNYVALE, Calif.--(BUSINESS WIRE)-- Yahoo! Inc. (NASDAQ: YHOO) CFO Ken Goldman will participate in a question-and-answer session at the Citi Global Technology Conference in New York.

The session is scheduled to begin on Wednesday, September 7, 2016, at 7:15 a.m. PT / 10:15 a.m. ET.

A live webcast of the session will be available on the Investor Relations website at http://yhoo.client.shareholder.com/events.cfm?CalendarID=5.

About Yahoo

Yahoo is a guide to digital information discovery, focused on informing, connecting, and entertaining users through its search, communications, and digital content products. By creating highly personalized experiences, Yahoo helps users discover the information that matters most to them around the world -- on mobile or desktop. Yahoo connects advertisers with target audiences through a streamlined advertising technology stack that combines the power of Yahoo's data, content, and technology. Yahoo is headquartered in Sunnyvale, California, and has offices located throughout the Americas, Asia Pacific (APAC) and the Europe, Middle East and Africa (EMEA) regions. For more information, visit the pressroom (pressroom.yahoo.net) or the Company's blog (yahoo.tumblr.com).

Yahoo and Yahoo Finance are the trademarks and/or registered trademarks of Yahoo! Inc.

All other names are trademarks and/or registered trademarks of their respective owners.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160831005177/en/

Yahoo! Inc.
Media Relations
Rebecca Neufeld, 408-349-4040
[email protected]
or
Investor Relations
Joon Huh, 408-349-3382
[email protected]

Source: Yahoo! Inc.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• CaringAI Presents Research at AAIC 2026 Showing Strong Clinician Agreement with AI-Powered Telephone Cognitive Screening
• Next Crypto to Explode in July 2026 as Bitcoin Bounces From $58K Low and Smart Money Rotates
• Hemab Therapeutics Presents New Clinical Data from HMB-002 in Von Willebrand Disease and Introduces HMB-003 for Heavy Menstrual Bleeding at the ISTH 2026 Congress